Pilot Study of Oxtellar XR (Oxcarbazepine Extended Release) in Neurology Patients With Trigeminal Neuralgia

Trial Profile

Pilot Study of Oxtellar XR (Oxcarbazepine Extended Release) in Neurology Patients With Trigeminal Neuralgia

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Feb 2018

At a glance

  • Drugs Oxcarbazepine (Primary)
  • Indications Trigeminal neuralgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
    • 26 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top